Product Information
CHEST CONGST-COUGH RELIEF TAB is a generic product labeled by AmerisourceBergen, priced at $0.0819 per EA under NDC 24385002671. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
20; 400 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
24385002671
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/1/2012
Pharmacological Classes
Price Statistics
The NADAC for CHEST CONGST-COUGH RELIEF TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0819 per EA |
|---|---|
| All-time high | $0.0877 (Aug 12, 2020) |
| All-time low | $0.0691 (Oct 22, 2014) |
| 52-week high | $0.0819 |
| 52-week low | $0.0779 |
| Median price | $0.0783 |
| Average price | $0.0778 |
| Largest weekly change | +13.7% (Jun 22, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan Hydrobromide / Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHEST CONGST-COUGH RELIEF TAB?
The current National Average Drug Acquisition Cost (NADAC) for CHEST CONGST-COUGH RELIEF TAB, manufactured by AmerisourceBergen, is $0.0819 per EA (NDC 24385002671), effective Sep 30, 2026.
How has the price of CHEST CONGST-COUGH RELIEF TAB changed over time?
Over the history we have for it, the NADAC for CHEST CONGST-COUGH RELIEF TAB has risen 14.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHEST CONGST-COUGH RELIEF TAB?
Since Nov 28, 2013, the NADAC for CHEST CONGST-COUGH RELIEF TAB has ranged from a low of $0.0691 (Oct 22, 2014) to a high of $0.0877 (Aug 12, 2020), with a median of $0.0783 per EA.
Are there cheaper alternatives to CHEST CONGST-COUGH RELIEF TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 7% below CHEST CONGST-COUGH RELIEF TAB.
Who manufactures CHEST CONGST-COUGH RELIEF TAB?
CHEST CONGST-COUGH RELIEF TAB (NDC 24385002671) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.